Kringle5,Kringle 5
1)Kringle 5Kringle5
1.Pharmacological properties of Kringle 5 and its application in ophthalmology;Kringle5的药理特性及其在眼科的应用
2.Human Plasminogen Kringle 5 DNA Clone with Eukaryotic System and Study on Anti-tumor Effect;重组人纤溶酶原Kringle5真核表达质粒的构建及其抗肿瘤作用的初步研究
3.Aim:To construct the plant shuttle expression plasmids containing the target gene kringle 5.目的 :构建含有目的基因kringle5的真核植物细胞穿梭表达载体。
2)deletion mutant of Kringle 5突变型Kringle5
3)kringle5 domainkringle5功能区
4)Kringle5Kringle5蛋白
1.Angiogenesis Inhibitor-Kringle5 Protein: Secretory Expression in Pichia Pastoris and Construction of Mammal Expression Plasmid;内源性血管生成抑制剂—Kringle5蛋白在毕赤酵母菌中分泌表达及其哺乳动物细胞分泌表达质粒的构建
5)angiogenesis inhibitor Kringle 5血管生长抑制剂Kringle5
6)recombinant plasminogen Kringle 5重组人纤溶酶原Kringle5
英文短句/例句

1.Human Plasminogen Kringle 5 DNA Clone with Eukaryotic System and Study on Anti-tumor Effect;重组人纤溶酶原Kringle5真核表达质粒的构建及其抗肿瘤作用的初步研究
2.recombinant human plasminogen重组体人纤溶酶原激活质
3.Pilot Production and Pharmacodynamics Study of Recombinant Human Microplasminogen;重组人微小纤溶酶原的中试及药效学研究
4.Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
5.Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;重组非糖基化尿激酶型纤溶酶原激活剂的研究
6.The Pegylation of Recombinant Human Plasminogen Kringle 5 and Preliminary Research on Its Antitumor Activity;重组人纤溶酶原kringle 5的PEG修饰和抗肿瘤作用初步研究
7.Expression,Production Purification and Identification of Recombinant Human Plasminogen Gene in Yeast重组人纤溶酶原基因的酵母表达、产物纯化及鉴定
8.Evaluation of the therapeutic effect of thrombolytic therapy with rt-PA and nursing intervention in patients with acute myocardial infarction急性心肌梗死重组组织型纤溶酶原激活剂溶栓治疗的观察及护理
9.Therapeutic effect observation of thrombolysis with rt-PA intravenous in recurrent cerebral infarction重组组织型纤溶酶原激活剂对再发性脑梗死静脉溶栓治疗评价
10.Therapeutic Effect of Ultra Earlier Thrombolysis of Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction重组组织型纤溶酶原激活剂超早期溶栓治疗急性脑梗死的疗效
11.Thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute cerebral infarction重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死19例
12.Intravenous thrombolytic therapy with recombinant-tissue plasminogen activator for super early stage of cerebral infarction重组组织型纤溶酶原激活物rt-PA静脉溶栓治疗超早期脑梗死
13.The Recombinant Human Tissue-type Plasminogen Activator in the Treatment of Deep Venous Thrombosis of the Lower Extremities重组组织型纤溶酶原激活剂治疗下肢深静脉血栓形成的临床应用
14.Experimental study on prevention of the peritoneal adhesion by recombinant tissue-type plasminogen activator on rats重组组织型纤溶酶原激活剂预防大鼠腹腔粘连的实验研究
15.Therapeutic effect evaluation of recombinant tissue plasminogen activator in hyper acute cerebral infarction重组组织型纤溶酶原激活剂治疗急性脑梗死的疗效评价
16.Expression, Purification and Functional Study of Recombinant Human Plasminogen Kringle 5 with Yeast Pichia Pastoris and Antiangiogenic Gene Therapy of Tumor;重组人纤溶酶原K5在毕赤酵母中的表达、纯化及其抗肿瘤新生血管生成基因治疗
17.Comparative study on intravenous rt-PA and uroninase thrombolytic strategy for acute myocardial infarction重组组织型纤溶酶原激活剂与尿激酶静脉内溶栓治疗急性心肌梗死的比较研究
18.Therapeutic effects of thrombolysis with rt-PA intravenous in patients with ultra-acute vertebrobasilar artery infarction重组组织型纤溶酶原激活剂超早期静脉溶栓治疗急性椎-基底动脉梗死的疗效观察
相关短句/例句

deletion mutant of Kringle 5突变型Kringle5
3)kringle5 domainkringle5功能区
4)Kringle5Kringle5蛋白
1.Angiogenesis Inhibitor-Kringle5 Protein: Secretory Expression in Pichia Pastoris and Construction of Mammal Expression Plasmid;内源性血管生成抑制剂—Kringle5蛋白在毕赤酵母菌中分泌表达及其哺乳动物细胞分泌表达质粒的构建
5)angiogenesis inhibitor Kringle 5血管生长抑制剂Kringle5
6)recombinant plasminogen Kringle 5重组人纤溶酶原Kringle5
延伸阅读

tRNA突变型tRNA突变型 tRNA的反密码子发生变化的突变型。也就是一种移码突变抑制基因或一个终链突变抑制基因;也可以是tRNA基因发生突变的结果,或某一种酶的结构基因突变的结果。这种酶具有改变tRNA结构的作用。